Health outcomes after stopping conjugated equine estrogens among postmenopausal women with prior hysterectomy: a randomized controlled trial.
LaCroix AZ, Chlebowski RT, Manson JE, Aragaki AK, Johnson KC, Martin L, Margolis KL, Stefanick ML, Brzyski R, Curb JD, Howard BV, Lewis CE, Wactawski-Wende J,
Fred Hutchinson Cancer Research Center, 1100 Fairview Ave N, M3-A410, PO 19024, Seattle, WA 98109. alacroix@whi.org.
Published 6 April 2011 in JAMA, 305(13): 1305-14.
Full-text of this article is available online (may require subscription).
Articles on Breast Cancer published 6 April 2011:
Health outcomes after stopping conjugated equine estrogens among postmenopausal women with prior hysterectomy: a randomized controlled trial. JAMA, 305(13): 1305-14.
[Abstract] [Full-text]
Health outcomes after stopping conjugated equine estrogens among postmenopausal women with prior hysterectomy: a randomized controlled trial. JAMA, 305(13): 1305-14.
[Abstract] [Full-text]
Articles on Breast Cancer published 22 March 2011:
Socioeconomic status and survival after an invasive breast cancer diagnosis. Cancer, 117(7): 1542-51.
[Abstract] [Full-text]
Breast implant-associated, ALK-negative, T-cell, anaplastic, large-cell lymphoma: establishment and characterization of a model cell line (TLBR-1) for this newly emerging clinical entity. Cancer, 117(7): 1478-89.
[Abstract] [Full-text]
Catechol-O-methyltransferase genotype modulates cancer treatment-related cognitive deficits in breast cancer survivors. Cancer, 117(7): 1369-76.
[Abstract] [Full-text]
Prognosis and pathology of screen-detected carcinomas: how different are they? Cancer, 117(7): 1360-8.
[Abstract] [Full-text]
CK8/18 expression, the basal phenotype, and family history in identifying BRCA1-associated breast cancer in the Ontario site of the breast cancer family registry. Cancer, 117(7): 1350-9.
[Abstract] [Full-text]
Breast cancer and fertility preservation. Fertil Steril, 95(5): 1535-43.
[Abstract] [Full-text]
© 2004-2011 Breast Cancer Research Today. All Rights Reserved.
| 
